Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Int Arch Allergy Immunol ; 184(8): 797-807, 2023.
Article in English | MEDLINE | ID: mdl-37231861

ABSTRACT

INTRODUCTION: Asthma is an inflammatory reaction mediated by type 2 helper T (Th2) cells and is known to increase eosinophil levels. Our previous study showed that stress-related asthma can cause neutrophilic and eosinophilic airway inflammation by suppressing immune tolerance. However, the mechanism of stress-induced neutrophilic and eosinophilic airway inflammation remains unclear. Therefore, to elucidate the cause of neutrophilic and eosinophilic inflammation, we investigated the immune response during the induction of airway inflammation. In addition, we focused on the relationship between immune response modulation immediately after stress exposure and the development of airway inflammation. METHODS: Asthmatic mice were induced by three phases using female BALB/c mice. During the first phase, the mice were made to inhale ovalbumin (OVA) to induce immune tolerance before sensitization. Some mice were exposed to restraint stress during the induction of immune tolerance. In the second phase, the mice were sensitized with OVA/alum intraperitoneal injections. In the final phase, onset of asthma was induced through OVA exposure. Asthma development was evaluated based on airway inflammation and T-cell differentiation. Microarray and qPCR analyses were used to enumerate candidate factors to investigate the starting point of immunological modification immediately after stress exposure. Furthermore, we focused on interleukin-1ß (IL-1ß), which initiates these immune modifications, and performed experiments using its receptor blocker interleukin-1 receptor antagonist (IL-1RA). RESULTS: Stress exposure during immune tolerance induction increased eosinophil and neutrophil airway infiltration. This inflammation was associated with decreased T regulatory cell levels and increased Th2 and Th17 levels in bronchial lymph node cells. Microarray and qPCR analyses showed that the initiation of Th17 differentiation might be triggered by stress exposure during tolerance induction. IL-1RA administration during stress exposure suppressed neutrophilic and eosinophilic airway inflammation via Th17 reduction and Treg increase. CONCLUSIONS: Our results show that psychological stress causes both eosinophilic and neutrophilic inflammatory responses due to the breakdown of immune tolerance. Furthermore, stress-induced inflammation can be abolished using IL-1RA.


Subject(s)
Asthma , Interleukin 1 Receptor Antagonist Protein , Animals , Female , Mice , Disease Models, Animal , Immune Tolerance , Immunity , Inflammation , Interleukin 1 Receptor Antagonist Protein/adverse effects , Interleukin 1 Receptor Antagonist Protein/metabolism , Interleukin-1beta/metabolism , Mice, Inbred BALB C , Neutrophils , Ovalbumin , Stress, Psychological/complications , Th17 Cells , Th2 Cells
2.
Yakugaku Zasshi ; 140(7): 937-941, 2020.
Article in Japanese | MEDLINE | ID: mdl-32612059

ABSTRACT

Studies on the drug saxagliptin (marketed in Japan since 2013) suggest favorable efficacy in hemodialysis patients, but included small sample sizes. Noting that some hemodialysis patients at our medical institution had been switched to saxagliptin 2.5 mg from treatment with other dipeptidyl peptidase-4 inhibitors, we decided to evaluate the effects of switching to saxagliptin on blood glucose control in these patients. The study included 11 patients. Before switching drugs, six of the patients used teneligliptin 20 mg and five used linagliptin 5 mg. Mean glycated albumin (GA) from before to 4 months after switching tended to increase in the previous users of teneligliptin 20 mg (18.4±3.0% to 19.5±2.7%) and tended to decrease in the previous users of linagliptin 5 mg (18.8±3.3% to 17.7±1.4%). Lack of a substantial change in GA when the previous users of teneligliptin 20 mg and linagliptin 5 mg were switched to saxagliptin 2.5 mg indicates that these three agents might have comparable antihyperglycemic profiles when used in patients on hemodialysis. Future research following from this pilot study must evaluate the risk of cardiac failure and incidences of adverse events in a larger population, to investigate the long-term efficacy and safety of switching to saxagliptin.


Subject(s)
Adamantane/analogs & derivatives , Blood Glucose/metabolism , Diabetes Mellitus/drug therapy , Dipeptides/administration & dosage , Drug Substitution , Renal Dialysis , Adamantane/administration & dosage , Adamantane/adverse effects , Adamantane/economics , Aged , Aged, 80 and over , Cost Savings , Diabetes Mellitus/blood , Dipeptides/adverse effects , Dipeptides/economics , Female , Glycation End Products, Advanced , Humans , Linagliptin , Male , Middle Aged , Pilot Projects , Pyrazoles , Serum Albumin/metabolism , Thiazolidines , Glycated Serum Albumin
3.
Chem Commun (Camb) ; 46(23): 4055-7, 2010 Jun 21.
Article in English | MEDLINE | ID: mdl-20361095

ABSTRACT

The first enantioselective total synthesis of (+)-stachyflin, a potential anti-influenza A virus agent, was achieved; the method features a BF(3).Et(2)O-induced domino epoxide-opening/rearrangement/cyclization reaction to stereoselectively form the requisite pentacyclic ring system in one step.


Subject(s)
Antiviral Agents/chemical synthesis , Sesquiterpenes/chemical synthesis , Humans , Influenza A virus/drug effects , Influenza, Human/drug therapy , Stachybotrys/chemistry , Stereoisomerism
4.
Chemistry ; 14(3): 829-37, 2008.
Article in English | MEDLINE | ID: mdl-17992684

ABSTRACT

Biologically important and structurally unique marine natural products avarone (1), avarol (2), neoavarone (3), neoavarol (4) and aureol (5), were efficiently synthesized in a unified manner starting from (+)-5-methyl-Wieland-Miescher ketone 10. The synthesis involved the following crucial steps: i) Sequential BF(3)Et(2)O-induced rearrangement/cyclization reaction of 2 and 4 to produce 5 with complete stereoselectivity in high yield (2 --> 5 and 4 --> 5); ii) strategic salcomine oxidation of the phenolic compounds 6 and 8 to derive the corresponding quinones 1 and 3 (6 --> 1 and 8 --> 3); and iii) Birch reductive alkylation of 10 with bromide 11 to construct the requisite carbon framework 12 (10 + 11 --> 12). An in vitro cytotoxicity assay of compounds 1-5 against human histiocytic lymphoma cells U937 determined the order of cytotoxic potency (3 > 1 > 5 > 2 > 4) and some novel aspects of structure-activity relationships.


Subject(s)
Biological Factors/chemical synthesis , Cyclohexenes/chemical synthesis , Sesquiterpenes/chemical synthesis , Biological Factors/chemistry , Cyclohexenes/chemistry , Molecular Conformation , Sesquiterpenes/chemistry , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...